LEP and metabolic syndrome: These findings were independent of a large panel of potential covariates; in fact, they were virtually unchanged following the inclusion in the regression model of total cholesterol or triglycerides, HDL, LDL, systolic and diastolic blood pressure, creatinine, metabolic syndrome, circulating leptin, or ongoing medications affecting PCSK9 levels (Table 3).